Investing.com - aTyr Pharma (NASDAQ: LIFE) reported first quarter EPS of $-0.230, better than the analyst estimate of $-0.240. Revenue for the quarter came in at $240K versus the consensus estimate of $27.5K.
aTyr Pharma's stock price closed at $1.60. It is down -9.090% in the last 3 months and down -21.950% in the last 12 months.
aTyr Pharma saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See aTyr Pharma's stock price’s past reactions to earnings here.
According to InvestingPro, aTyr Pharma's Financial Health score is "fair performance".
Check out aTyr Pharma's recent earnings performance, and aTyr Pharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar